131 related articles for article (PubMed ID: 25509357)
1. [Apoptin enhances the oncolytic activity of vaccinia virus].
Kochneva GV; Babkina IN; Lupan TA; Grazhdantseva AA; Iudin PV; Sivolobova GF; Shvalov AN; Popov EG; Babkin IV; Netesov SV; Chumakov PM
Mol Biol (Mosk); 2013; 47(5):842-52. PubMed ID: 25509357
[TBL] [Abstract][Full Text] [Related]
2. Apoptin enhances the oncolytic properties of Newcastle disease virus.
Wu Y; Zhang X; Wang X; Wang L; Hu S; Liu X; Meng S
Intervirology; 2012; 55(4):276-86. PubMed ID: 21865658
[TBL] [Abstract][Full Text] [Related]
3. Apoptin enhances the oncolytic properties of vaccinia virus and modifies mechanisms of tumor regression.
Kochneva G; Zonov E; Grazhdantseva A; Yunusova A; Sibolobova G; Popov E; Taranov O; Netesov S; Chumakov P; Ryabchikova E
Oncotarget; 2014 Nov; 5(22):11269-82. PubMed ID: 25358248
[TBL] [Abstract][Full Text] [Related]
4. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL
Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma.
Liu L; Wu W; Zhu G; Liu L; Guan G; Li X; Jin N; Chi B
Int J Mol Med; 2012 Oct; 30(4):747-54. PubMed ID: 22842823
[TBL] [Abstract][Full Text] [Related]
6. Apoptin as a potential viral gene oncotherapeutic agent.
Singh PK; Tiwari AK; Rajmani RS; Kumar GR; Chaturvedi U; Saxena L; Saxena S; Doley J; Sahoo AP; Santra L; Saxena M; Kumar S; Sharma B
Appl Biochem Biotechnol; 2015 May; 176(1):196-212. PubMed ID: 25809990
[TBL] [Abstract][Full Text] [Related]
7. Next-generation oncolytic vaccinia vectors.
Thorne SH
Methods Mol Biol; 2012; 797():205-15. PubMed ID: 21948478
[TBL] [Abstract][Full Text] [Related]
8. [Development of the drug oncolytic immunotherapy based on vaccinia viruses (Vaccinia virus, Orthopoxvirus, Chordopoxvirinae, Poxviridae) against breast cancer.].
Bauer TV; Tregubchak TV; Maksyutov AZ; Kolosova IV; Maksyutov RA; Gavrilova EV
Vopr Virusol; 2020; 65(1):49-56. PubMed ID: 32496721
[TBL] [Abstract][Full Text] [Related]
9. C-terminal region of apoptin affects chicken anemia virus replication and virulence.
Wang Y; Song X; Gao H; Wang X; Hu Y; Gao Y; Qi X; Qin L; Lin H; Gao L; Yao S; Han C; Wang X; Chen H
Virol J; 2017 Feb; 14(1):38. PubMed ID: 28222746
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative Effects of Recombinant Apoptin on Lung and Breast Cancer Cell Lines.
Ezami Razliqi M; Olad G; Dorostkar R; Heydari S; Esmaeili Gouvarchin Ghaleh H
Arch Iran Med; 2020 Sep; 23(9):593-599. PubMed ID: 32979905
[TBL] [Abstract][Full Text] [Related]
11. Progress in gene therapy using oncolytic vaccinia virus as vectors.
Yang X; Huang B; Deng L; Hu Z
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2433-2440. PubMed ID: 30293118
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic vaccinia virus: from bedside to benchtop and back.
Thorne SH
Curr Opin Mol Ther; 2008 Aug; 10(4):387-92. PubMed ID: 18683104
[TBL] [Abstract][Full Text] [Related]
13. A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancers.
Haddad D; Chen N; Zhang Q; Chen CH; Yu YA; Gonzalez L; Aguilar J; Li P; Wong J; Szalay AA; Fong Y
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S665-74. PubMed ID: 22258815
[TBL] [Abstract][Full Text] [Related]
14. Potent growth-inhibitory effect of a dual cancer-specific oncolytic adenovirus expressing apoptin on prostate carcinoma.
Zhang M; Wang J; Li C; Hu N; Wang K; Ji H; He D; Quan C; Li X; Jin N; Li Y
Int J Oncol; 2013 Mar; 42(3):1052-60. PubMed ID: 23338489
[TBL] [Abstract][Full Text] [Related]
15. Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy.
Kochneva G; Sivolobova G; Tkacheva A; Grazhdantseva A; Troitskaya O; Nushtaeva A; Tkachenko A; Kuligina E; Richter V; Koval O
Oncotarget; 2016 Nov; 7(45):74171-74188. PubMed ID: 27708236
[TBL] [Abstract][Full Text] [Related]
16. Recombinant adenoviruses expressing apoptin suppress the growth of MCF‑7 breast cancer cells and affect cell autophagy.
Chen S; Li YQ; Yin XZ; Li SZ; Zhu YL; Fan YY; Li WJ; Cui YL; Zhao J; Li X; Zhang QG; Jin NY
Oncol Rep; 2019 May; 41(5):2818-2832. PubMed ID: 30896879
[TBL] [Abstract][Full Text] [Related]
17. Activation of the Chicken Anemia Virus Apoptin Protein by Chk1/2 Phosphorylation Is Required for Apoptotic Activity and Efficient Viral Replication.
Kucharski TJ; Ng TF; Sharon DM; Navid-Azarbaijani P; Tavassoli M; Teodoro JG
J Virol; 2016 Oct; 90(20):9433-45. PubMed ID: 27512067
[TBL] [Abstract][Full Text] [Related]
18. Vaccinia virus GLV-1h237 carrying a Walker A motif mutation of mouse Cdc6 protein enhances human breast tumor therapy in mouse xenografts.
Hofmann E; Grummt F; Szalay AA
Int J Oncol; 2011 Mar; 38(3):871-8. PubMed ID: 21249314
[TBL] [Abstract][Full Text] [Related]
19. United virus: the oncolytic tag-team against cancer!
Le Boeuf F; Bell JC
Cytokine Growth Factor Rev; 2010; 21(2-3):205-11. PubMed ID: 20227326
[TBL] [Abstract][Full Text] [Related]
20. [Oncolytic poxviruses].
Kochneva GV; Sivolobova GF; Iudina KV; Babkin IV; Chumakov PM; Netesov SV
Mol Gen Mikrobiol Virusol; 2012; (1):8-15. PubMed ID: 22702138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
